Polymorphism of FGD4 and myelosuppression in patients with esophageal squamous cell carcinoma

Chemotherapy-related adverse events may restrain taxane/cisplatin administration as a regimen for patients with esophageal squamous cell carcinoma. Genetic polymorphisms may contribute to adverse event susceptibility. The authors genotyped ten SNPs from five genes (rs1045642, rs2032582 and rs3213619...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Future oncology (London, England) England), 2021-06, Vol.17 (18), p.2351-2363
Hauptverfasser:	Yang, Ying, Jia, Jun, Sun, Zhiwei, Liu, Chuanling, Li, Ziwei, Xiao, Yanjie, Yu, Jing, Du, Feng, Shi, Youwu, Sun, Jing, Shui, Jing, Zhang, Xiaodong
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!